25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

In8bio Inc
Buy, Hold or Sell?

Let's analyze In8bio together

I guess you are interested in In8bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of In8bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about In8bio Inc

I send you an email if I find something interesting about In8bio Inc.

1. Quick Overview

1.1. Quick analysis of In8bio (30 sec.)










1.2. What can you expect buying and holding a share of In8bio? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.12
Expected worth in 1 year
$-0.01
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$-0.13
Return On Investment
-42.2%

For what price can you sell your share?

Current Price per Share
$0.30
Expected price per share
$0.2198 - $0.5
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of In8bio (5 min.)




Live pricePrice per Share (EOD)
$0.30
Intrinsic Value Per Share
$-2.35 - $-2.69
Total Value Per Share
$-2.24 - $-2.57

2.2. Growth of In8bio (5 min.)




Is In8bio growing?

Current yearPrevious yearGrowGrow %
How rich?$8.5m$19.7m-$3.6m-22.3%

How much money is In8bio making?

Current yearPrevious yearGrowGrow %
Making money-$7.9m-$7.4m-$564.5k-7.1%
Net Profit Margin-50.7%-525.4%--

How much money comes from the company's main activities?

2.3. Financial Health of In8bio (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#640 / 949

Most Revenue
#503 / 949

Most Profit
#512 / 949

Most Efficient
#388 / 949
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of In8bio?

Welcome investor! In8bio's management wants to use your money to grow the business. In return you get a share of In8bio.

First you should know what it really means to hold a share of In8bio. And how you can make/lose money.

Speculation

The Price per Share of In8bio is $0.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of In8bio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in In8bio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.12. Based on the TTM, the Book Value Change Per Share is $-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of In8bio.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.10-32.6%-0.11-36.6%-0.10-34.6%-0.08-27.2%-0.08-27.2%
Usd Book Value Change Per Share-0.07-23.1%-0.03-10.5%-0.04-13.6%0.012.2%0.012.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.07-23.1%-0.03-10.5%-0.04-13.6%0.012.2%0.012.2%
Usd Price Per Share0.27-0.92-1.55-1.60-1.60-
Price to Earnings Ratio-0.69--2.06--3.70--5.21--5.21-
Price-to-Total Gains Ratio-3.89--4.30--9.18--9.62--9.62-
Price to Book Ratio2.28-3.92-5.59-4.24-4.24-
Price-to-Total Gains Ratio-3.89--4.30--9.18--9.62--9.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.3
Number of shares3333
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.030.01
Usd Total Gains Per Share-0.030.01
Gains per Quarter (3333 shares)-105.4221.94
Gains per Year (3333 shares)-421.6687.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-422-43208878
20-843-8540176166
30-1265-12760263254
40-1687-16980351342
50-2108-21200439430
60-2530-25420527518
70-2952-29640614606
80-3373-33860702694
90-3795-38080790782
100-4217-42300878870

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.018.00.00.0%0.018.00.00.0%0.018.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%6.011.01.033.3%6.011.01.033.3%6.011.01.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%6.011.01.033.3%6.011.01.033.3%6.011.01.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of In8bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.069-0.032-54%-0.041-41%0.007-1155%0.007-1155%
Book Value Per Share--0.1180.223-47%0.273-57%0.279-58%0.279-58%
Current Ratio--1.8443.293-44%4.085-55%6.868-73%6.868-73%
Debt To Asset Ratio--0.4620.358+29%0.305+51%0.300+54%0.300+54%
Debt To Equity Ratio--0.8590.580+48%0.441+95%0.682+26%0.682+26%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--16193489.92070497019.848-77%118248650.560-86%173800523.941-91%173800523.941-91%
Eps---0.098-0.110+12%-0.104+6%-0.082-17%-0.082-17%
Ev To Ebitda Ratio---0.757-2.349+210%-4.040+434%-8.217+986%-8.217+986%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.083-0.087+4%-0.097+17%-0.070-16%-0.070-16%
Free Cash Flow To Equity Per Share---0.085-0.030-64%-0.051-40%0.000-100%0.000-100%
Gross Profit Margin--1.0001.039-4%1.0000%1.009-1%1.009-1%
Intrinsic Value_10Y_max---2.686--------
Intrinsic Value_10Y_min---2.354--------
Intrinsic Value_1Y_max---0.332--------
Intrinsic Value_1Y_min---0.326--------
Intrinsic Value_3Y_max---0.949--------
Intrinsic Value_3Y_min---0.907--------
Intrinsic Value_5Y_max---1.509--------
Intrinsic Value_5Y_min---1.404--------
Market Cap21744988.800+10%19570489.92066630269.848-71%112167900.560-83%115639045.068-83%115639045.068-83%
Net Profit Margin----0.5070%-5.2540%-1.2800%-1.2800%
Operating Margin----0.5290%-6.1480%-1.4840%-1.4840%
Operating Ratio---0.507-100%6.148-100%1.479-100%1.479-100%
Pb Ratio2.532+10%2.2793.919-42%5.586-59%4.242-46%4.242-46%
Pe Ratio-0.767-11%-0.690-2.064+199%-3.701+436%-5.208+654%-5.208+654%
Price Per Share0.300+10%0.2700.919-71%1.548-83%1.595-83%1.595-83%
Price To Free Cash Flow Ratio-0.902-11%-0.812-2.764+240%-4.000+393%-5.810+616%-5.810+616%
Price To Total Gains Ratio-4.320-11%-3.888-4.304+11%-9.185+136%-9.615+147%-9.615+147%
Quick Ratio--1.1012.645-58%3.314-67%5.936-81%5.936-81%
Return On Assets---0.444-0.347-22%-0.263-41%-0.272-39%-0.272-39%
Return On Equity---0.825-0.563-32%-0.378-54%-0.592-28%-0.592-28%
Total Gains Per Share---0.069-0.032-54%-0.041-41%0.007-1155%0.007-1155%
Usd Book Value--8588000.00016168000.000-47%19769250.000-57%20217111.111-58%20217111.111-58%
Usd Book Value Change Per Share---0.069-0.032-54%-0.041-41%0.007-1155%0.007-1155%
Usd Book Value Per Share--0.1180.223-47%0.273-57%0.279-58%0.279-58%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--16193489.92070497019.848-77%118248650.560-86%173800523.941-91%173800523.941-91%
Usd Eps---0.098-0.110+12%-0.104+6%-0.082-17%-0.082-17%
Usd Free Cash Flow---6028000.000-6278500.000+4%-7057500.000+17%-5062944.444-16%-5062944.444-16%
Usd Free Cash Flow Per Share---0.083-0.087+4%-0.097+17%-0.070-16%-0.070-16%
Usd Free Cash Flow To Equity Per Share---0.085-0.030-64%-0.051-40%0.000-100%0.000-100%
Usd Market Cap21744988.800+10%19570489.92066630269.848-71%112167900.560-83%115639045.068-83%115639045.068-83%
Usd Price Per Share0.300+10%0.2700.919-71%1.548-83%1.595-83%1.595-83%
Usd Profit---7086000.000-7968750.000+12%-7404250.000+4%-5763000.000-19%-5763000.000-19%
Usd Revenue---937000.000-100%82500.000-100%226555.556-100%226555.556-100%
Usd Total Gains Per Share---0.069-0.032-54%-0.041-41%0.007-1155%0.007-1155%
 EOD+5 -3MRQTTM+11 -24YOY+11 -235Y+5 -3010Y+5 -30

3.3 Fundamental Score

Let's check the fundamental score of In8bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.767
Price to Book Ratio (EOD)Between0-12.532
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.101
Current Ratio (MRQ)Greater than11.844
Debt to Asset Ratio (MRQ)Less than10.462
Debt to Equity Ratio (MRQ)Less than10.859
Return on Equity (MRQ)Greater than0.15-0.825
Return on Assets (MRQ)Greater than0.05-0.444
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of In8bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.772
Ma 20Greater thanMa 500.323
Ma 50Greater thanMa 1000.298
Ma 100Greater thanMa 2000.435
OpenGreater thanClose0.310
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About In8bio Inc

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of solid and liquid tumors. Its lead product candidates include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM and other cancers; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company develops INB-300 and INB-500 that are in preclinical phase for treatment of acute myeloid leukemia, and other solid and hematological tumor types. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.

Fundamental data was last updated by Penke on 2024-12-05 22:42:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit In8bio earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of In8bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-50.7%+50.7%
TTM-50.7%YOY-525.4%+474.7%
TTM-50.7%5Y-128.0%+77.3%
5Y-128.0%10Y-128.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--108.0%+108.0%
TTM-50.7%-218.6%+167.9%
YOY-525.4%-210.1%-315.3%
5Y-128.0%-339.1%+211.1%
10Y-128.0%-464.5%+336.5%
4.3.1.2. Return on Assets

Shows how efficient In8bio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • -44.4% Return on Assets means that In8bio generated $-0.44 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of In8bio Inc:

  • The MRQ is -44.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -34.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-44.4%TTM-34.7%-9.7%
TTM-34.7%YOY-26.3%-8.4%
TTM-34.7%5Y-27.2%-7.5%
5Y-27.2%10Y-27.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-44.4%-11.3%-33.1%
TTM-34.7%-11.8%-22.9%
YOY-26.3%-11.3%-15.0%
5Y-27.2%-12.6%-14.6%
10Y-27.2%-14.2%-13.0%
4.3.1.3. Return on Equity

Shows how efficient In8bio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • -82.5% Return on Equity means In8bio generated $-0.83 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of In8bio Inc:

  • The MRQ is -82.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -56.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-82.5%TTM-56.3%-26.2%
TTM-56.3%YOY-37.8%-18.5%
TTM-56.3%5Y-59.2%+2.9%
5Y-59.2%10Y-59.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-82.5%-14.2%-68.3%
TTM-56.3%-15.9%-40.4%
YOY-37.8%-14.4%-23.4%
5Y-59.2%-18.5%-40.7%
10Y-59.2%-19.5%-39.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of In8bio Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient In8bio is operating .

  • Measures how much profit In8bio makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of In8bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-52.9%+52.9%
TTM-52.9%YOY-614.8%+561.9%
TTM-52.9%5Y-148.4%+95.5%
5Y-148.4%10Y-148.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.6%+204.6%
TTM-52.9%-313.2%+260.3%
YOY-614.8%-219.0%-395.8%
5Y-148.4%-388.9%+240.5%
10Y-148.4%-495.6%+347.2%
4.3.2.2. Operating Ratio

Measures how efficient In8bio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of In8bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.507-0.507
TTM0.507YOY6.148-5.641
TTM0.5075Y1.479-0.972
5Y1.47910Y1.4790.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.340-2.340
TTM0.5073.187-2.680
YOY6.1483.282+2.866
5Y1.4794.814-3.335
10Y1.4796.494-5.015
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of In8bio Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if In8bio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.84 means the company has $1.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of In8bio Inc:

  • The MRQ is 1.844. The company is able to pay all its short-term debts. +1
  • The TTM is 3.293. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.844TTM3.293-1.449
TTM3.293YOY4.085-0.792
TTM3.2935Y6.868-3.575
5Y6.86810Y6.8680.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8443.645-1.801
TTM3.2933.883-0.590
YOY4.0854.666-0.581
5Y6.8685.964+0.904
10Y6.8686.265+0.603
4.4.3.2. Quick Ratio

Measures if In8bio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • A Quick Ratio of 1.10 means the company can pay off $1.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of In8bio Inc:

  • The MRQ is 1.101. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 2.645. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.101TTM2.645-1.544
TTM2.645YOY3.314-0.670
TTM2.6455Y5.936-3.291
5Y5.93610Y5.9360.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1013.014-1.913
TTM2.6453.418-0.773
YOY3.3144.456-1.142
5Y5.9365.970-0.034
10Y5.9366.424-0.488
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of In8bio Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of In8bio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare In8bio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.46 means that In8bio assets are financed with 46.2% credit (debt) and the remaining percentage (100% - 46.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of In8bio Inc:

  • The MRQ is 0.462. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.358. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.462TTM0.358+0.104
TTM0.358YOY0.305+0.053
TTM0.3585Y0.300+0.058
5Y0.30010Y0.3000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4620.350+0.112
TTM0.3580.341+0.017
YOY0.3050.310-0.005
5Y0.3000.365-0.065
10Y0.3000.382-0.082
4.5.4.2. Debt to Equity Ratio

Measures if In8bio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare In8bio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 85.9% means that company has $0.86 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of In8bio Inc:

  • The MRQ is 0.859. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.580. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.859TTM0.580+0.279
TTM0.580YOY0.441+0.139
TTM0.5805Y0.682-0.102
5Y0.68210Y0.6820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8590.394+0.465
TTM0.5800.432+0.148
YOY0.4410.380+0.061
5Y0.6820.451+0.231
10Y0.6820.490+0.192
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings In8bio generates.

  • Above 15 is considered overpriced but always compare In8bio to the Biotechnology industry mean.
  • A PE ratio of -0.69 means the investor is paying $-0.69 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of In8bio Inc:

  • The EOD is -0.767. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.690. Based on the earnings, the company is expensive. -2
  • The TTM is -2.064. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.767MRQ-0.690-0.077
MRQ-0.690TTM-2.064+1.374
TTM-2.064YOY-3.701+1.636
TTM-2.0645Y-5.208+3.143
5Y-5.20810Y-5.2080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.767-2.315+1.548
MRQ-0.690-2.491+1.801
TTM-2.064-3.156+1.092
YOY-3.701-3.274-0.427
5Y-5.208-6.037+0.829
10Y-5.208-6.785+1.577
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of In8bio Inc:

  • The EOD is -0.902. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.812. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.764. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.902MRQ-0.812-0.090
MRQ-0.812TTM-2.764+1.952
TTM-2.764YOY-4.000+1.236
TTM-2.7645Y-5.810+3.047
5Y-5.81010Y-5.8100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.902-2.985+2.083
MRQ-0.812-3.361+2.549
TTM-2.764-3.734+0.970
YOY-4.000-4.557+0.557
5Y-5.810-8.327+2.517
10Y-5.810-9.311+3.501
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of In8bio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.28 means the investor is paying $2.28 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of In8bio Inc:

  • The EOD is 2.532. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.279. Based on the equity, the company is underpriced. +1
  • The TTM is 3.919. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.532MRQ2.279+0.253
MRQ2.279TTM3.919-1.641
TTM3.919YOY5.586-1.667
TTM3.9195Y4.242-0.323
5Y4.24210Y4.2420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.5321.919+0.613
MRQ2.2792.051+0.228
TTM3.9192.374+1.545
YOY5.5862.454+3.132
5Y4.2423.737+0.505
10Y4.2424.378-0.136
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of In8bio Inc.

4.8.1. Institutions holding In8bio Inc

Institutions are holding 46.457% of the shares of In8bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30AIGH Capital Management, LLC2.31040.12751674638-453360-21.3045
2024-09-30Vanguard Group Inc1.96440142389700
2024-09-30683 Capital Management LLC1.86290.02771350304759493128.5509
2024-09-30Sigma Planning Corp1.17450.00785128025160041.9557
2024-09-30Ensign Peak Advisors Inc1.1440.0004829176-289090-25.8516
2024-09-30Alyeska Investment Group, L.P.0.59990.0006434809-206199-32.1679
2024-09-30Geode Capital Management, LLC0.45430329274119043.7508
2024-09-30State Street Corp0.122408874600
2024-09-30Texas Capital Bank Wealth Management Services Inc0.10850.00217862400
2024-09-30Voss Capital LLC0.08830.001464000-27000-29.6703
2024-06-30BlackRock Inc0.078705708028876102.3826
2024-06-30Rock Creek Group, LP0.07230.005952390-98924-65.3766
2024-09-30Overbrook Management Corp0.04660.00213375600
2024-09-30Northern Trust Corp0.0414030005-46133-60.5913
2024-09-30UBS Group AG0.0362026270262700
2024-09-30Tower Research Capital LLC0.01820.0001131899404248.4544
2024-09-30LPL Financial Corp0.017012350123500
2024-06-30Westside Investment Management, Inc.0.01660.00231200000
2024-09-30HRT FINANCIAL LLC0.01550112524394.0599
2024-09-30HighTower Advisors, LLC0.013801000000
Total 10.18590.17717383040-20370-0.3%

4.9.2. Funds holding In8bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv1.3141095248700
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr0.65040.000147141000
2024-09-30Fidelity Extended Market Index0.24410.0001176938-715-0.4025
2024-09-30Fidelity Total Market Index0.084506122800
2024-11-27iShares Micro-Cap ETF0.07110.00155155400
2024-09-30Fidelity Series Total Market Index0.050103634500
2024-09-30Fidelity Nasdaq Composite Index0.039502866400
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.03920.00012843500
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.03160.000122910700.3065
2024-09-30Spartan Extended Market Index Pool E0.01860.0001134707155.6056
2024-10-31State St US Extended Mkt Indx NL Cl C0.01810.00021310000
2024-09-30Spartan Total Market Index Pool E0.017201247400
2024-06-30SSgA U.S. Total Market Index Strategy0.00740.000153734883996.5306
2024-09-301290 VT Micro Cap K0.00660.0008477800
2024-09-30Northern Trust Wilshire 50000.00220157000
2024-09-30Fidelity U.S. Equity Index Ins Trust0.0002015500
Total 2.59490.00311880891+4953+0.3%

5.3. Insider Transactions

Insiders are holding 21.559% of the shares of In8bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-13Jeremy R GraffBUY25000.95
2023-08-25Patrick MccallBUY10001.03
2023-08-24William Tai-wei HoBUY238001.05
2022-08-16Emily FairbairnBUY7894731.9
2022-08-16Kate RochlinBUY52631.9
2022-08-16Lawrence LambBUY5261.9
2022-08-16Trishna GoswamiBUY26311.9
2022-08-16William Tai-wei HoBUY263151.9
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Net Debt  -7,592-8,797-16,3899,089-7,3002,981-4,3195,7901,471



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets15,966
Total Liabilities7,378
Total Stockholder Equity8,588
 As reported
Total Liabilities 7,378
Total Stockholder Equity+ 8,588
Total Assets = 15,966

Assets

Total Assets15,966
Total Current Assets6,703
Long-term Assets9,263
Total Current Assets
Cash And Cash Equivalents 4,001
Other Current Assets 2,702
Total Current Assets  (as reported)6,703
Total Current Assets  (calculated)6,703
+/-0
Long-term Assets
Property Plant Equipment 8,499
Long-term Assets Other 764
Long-term Assets  (as reported)9,263
Long-term Assets  (calculated)9,263
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,635
Long-term Liabilities3,743
Total Stockholder Equity8,588
Total Current Liabilities
Short-term Debt 1,729
Accounts payable 1,137
Other Current Liabilities 769
Total Current Liabilities  (as reported)3,635
Total Current Liabilities  (calculated)3,635
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)3,743
Long-term Liabilities  (calculated)0
+/- 3,743
Total Stockholder Equity
Common Stock5
Retained Earnings -115,496
Other Stockholders Equity 124,079
Total Stockholder Equity (as reported)8,588
Total Stockholder Equity (calculated)8,588
+/-0
Other
Cash and Short Term Investments 4,001
Common Stock Shares Outstanding 47,321
Liabilities and Stockholders Equity 15,966
Net Debt 1,471
Net Working Capital 3,068
Short Long Term Debt Total 5,472



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-06-302019-03-312018-12-312018-06-302018-03-312017-12-31
> Total Assets 
0
0
0
0
0
0
1,130
0
3,647
0
20,910
20,423
17,564
47,134
42,223
36,538
30,988
38,383
33,039
24,678
29,718
26,208
33,709
25,549
22,496
15,966
15,96622,49625,54933,70926,20829,71824,67833,03938,38330,98836,53842,22347,13417,56420,42320,91003,64701,130000000
   > Total Current Assets 
0
0
0
0
0
0
763
0
3,325
18,144
18,144
15,372
12,167
43,877
38,980
33,274
26,999
29,654
22,234
14,402
19,465
16,549
24,625
15,755
12,682
6,703
6,70312,68215,75524,62516,54919,46514,40222,23429,65426,99933,27438,98043,87712,16715,37218,14418,1443,3250763000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
610
0
3,180
0
17,994
15,052
11,999
40,675
37,021
32,107
25,742
27,647
18,182
10,860
16,993
12,854
21,282
13,015
10,217
4,001
4,00110,21713,01521,28212,85416,99310,86018,18227,64725,74232,10737,02140,67511,99915,05217,99403,1800610000000
       Other Current Assets 
0
0
0
0
0
0
48
0
145
0
150
320
168
35
1,959
1,167
1,257
2,007
232
3,542
277
262
3,343
2,740
2,465
2,702
2,7022,4652,7403,3432622773,5422322,0071,2571,1671,959351683201500145048000000
   > Long-term Assets 
0
0
0
0
0
0
367
0
322
0
2,766
5,051
5,397
3,257
3,243
3,264
3,989
8,729
10,805
10,276
10,253
9,659
9,084
9,794
9,814
9,263
9,2639,8149,7949,0849,65910,25310,27610,8058,7293,9893,2643,2433,2575,3975,0512,76603220367000000
       Property Plant Equipment 
0
0
0
0
0
0
274
0
230
186
186
1,776
1,894
2,848
2,834
2,855
3,491
8,120
10,172
9,768
9,745
9,150
8,573
9,218
9,235
8,499
8,4999,2359,2188,5739,1509,7459,76810,1728,1203,4912,8552,8342,8481,8941,7761861862300274000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
3,362
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000003,362000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
126
126
0
0
0
0
0
0
0
000000012612600000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
2,580
2,580
3,275
3,503
409
409
409
498
483
0
0
508
0
0
0
0
0
00000508004834984094094093,5033,2752,5802,580000000000
> Total Liabilities 
0
0
0
0
0
0
1,476
0
2,812
0
2,589
4,104
3,903
4,096
4,040
3,703
4,420
8,819
10,307
7,890
7,919
8,450
8,772
8,023
8,875
7,378
7,3788,8758,0238,7728,4507,9197,89010,3078,8194,4203,7034,0404,0963,9034,1042,58902,81201,476000000
   > Total Current Liabilities 
0
0
0
0
0
0
647
0
1,867
2,572
2,572
3,062
2,773
2,160
2,256
2,068
2,972
4,900
5,822
3,748
3,781
4,686
5,393
3,844
4,759
3,635
3,6354,7593,8445,3934,6863,7813,7485,8224,9002,9722,0682,2562,1602,7733,0622,5722,5721,8670647000000
       Short-term Debt 
0
0
0
0
0
0
0
0
58
0
174
770
826
628
626
631
560
915
1,389
1,386
1,522
1,498
3,028
1,536
3,564
1,729
1,7293,5641,5363,0281,4981,5221,3861,38991556063162662882677017405800000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
58
0
174
174
174
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000017417417405800000000
       Accounts payable 
0
0
0
0
0
0
560
0
561
620
620
660
462
692
395
553
887
1,108
2,091
870
585
748
924
1,413
1,444
1,137
1,1371,4441,4139247485858702,0911,1088875533956924626606206205610560000000
       Other Current Liabilities 
0
0
0
0
0
0
87
0
1,248
876
1,778
1,632
1,485
840
1,235
884
1,525
2,877
2,342
1,492
1,674
2,440
1,441
895
-249
769
769-2498951,4412,4401,6741,4922,3422,8771,5258841,2358401,4851,6321,7788761,248087000000
   > Long-term Liabilities 
0
0
0
0
0
0
829
0
945
0
17
1,042
1,130
1,936
1,784
1,635
1,448
3,919
4,485
4,142
4,138
3,764
3,379
4,179
4,116
3,743
3,7434,1164,1793,3793,7644,1384,1424,4853,9191,4481,6351,7841,9361,1301,0421709450829000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
34,900
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000034,900000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
17
17
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001717000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
2,439
2,439
3,134
3,362
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000003,3623,1342,4392,439000000000
> Total Stockholder Equity
0
0
0
0
0
0
-346
0
835
0
18,321
16,319
13,661
43,038
38,183
32,835
26,568
29,564
22,732
16,788
21,799
17,758
24,937
17,526
13,621
8,588
8,58813,62117,52624,93717,75821,79916,78822,73229,56426,56832,83538,18343,03813,66116,31918,32108350-346000000
   Common Stock
0
0
0
0
0
0
1
0
1
1
1
1
1
3
2
2
2
3
3
3
4
4
4
4
5
5
55444433322231111101000000
   Retained Earnings Total Equity00000-76,452-68,73700000-26,842-23,451000000000000
   Accumulated Other Comprehensive Income 000000000000-47,1340-27900-2130-169000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
2,211
69,877
0
0
0
0
0
85,522
98,247
0
0
0
0
0
0000098,24785,5220000069,8772,211000000000000
   Treasury Stock00000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
238
0
523
0
1,458
1,819
2,211
69,877
70,872
71,669
72,581
82,975
83,941
85,522
98,247
101,375
116,152
117,303
122,026
124,079
124,079122,026117,303116,152101,37598,24785,52283,94182,97572,58171,66970,87269,8772,2111,8191,45805230238000000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-2,501
Gross Profit-2,501-2,501
 
Operating Income (+$)
Gross Profit-2,501
Operating Expense-30,337
Operating Income-30,337-32,838
 
Operating Expense (+$)
Research Development16,827
Selling General Administrative13,510
Selling And Marketing Expenses2,501
Operating Expense30,33732,838
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-30,337
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-30,007-30,667
EBIT - interestExpense = -30,337
-62,845
-30,007
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-30,337-30,007
Earnings Before Interest and Taxes (EBITDA)-28,504
 
After tax Income (+$)
Income Before Tax-30,007
Tax Provision-0
Net Income From Continuing Ops-30,007-30,007
Net Income-30,007
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses30,337
Total Other Income/Expenses Net3300
 

Technical Analysis of In8bio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of In8bio. The general trend of In8bio is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine In8bio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of In8bio Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.37 < 0.41 < 0.5.

The bearish price targets are: 0.29 > 0.2621 > 0.2198.

Tweet this
In8bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of In8bio Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

In8bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of In8bio Inc. The current macd is -0.00082687.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the In8bio price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for In8bio. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the In8bio price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
In8bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartIn8bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of In8bio Inc. The current adx is 42.43.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy In8bio shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
In8bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of In8bio Inc. The current sar is 0.2707977.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
In8bio Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of In8bio Inc. The current rsi is 46.77. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
In8bio Inc Daily Relative Strength Index (RSI) ChartIn8bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of In8bio Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the In8bio price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
In8bio Inc Daily Stochastic Oscillator ChartIn8bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of In8bio Inc. The current cci is -121.20002661.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
In8bio Inc Daily Commodity Channel Index (CCI) ChartIn8bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of In8bio Inc. The current cmo is -10.27484227.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
In8bio Inc Daily Chande Momentum Oscillator (CMO) ChartIn8bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of In8bio Inc. The current willr is -91.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
In8bio Inc Daily Williams %R ChartIn8bio Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of In8bio Inc.

In8bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of In8bio Inc. The current atr is 0.04029287.

In8bio Inc Daily Average True Range (ATR) ChartIn8bio Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of In8bio Inc. The current obv is 223,744,098.

In8bio Inc Daily On-Balance Volume (OBV) ChartIn8bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of In8bio Inc. The current mfi is 57.54.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
In8bio Inc Daily Money Flow Index (MFI) ChartIn8bio Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for In8bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

In8bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of In8bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.772
Ma 20Greater thanMa 500.323
Ma 50Greater thanMa 1000.298
Ma 100Greater thanMa 2000.435
OpenGreater thanClose0.310
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of In8bio with someone you think should read this too:
  • Are you bullish or bearish on In8bio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about In8bio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about In8bio Inc

I send you an email if I find something interesting about In8bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about In8bio Inc.

Receive notifications about In8bio Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.